News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
646,915 Results
Type
Article (32967)
Company Profile (640)
Press Release (613308)
Multimedia
Podcasts (54)
Webinars (11)
Section
Business (196790)
Career Advice (2133)
Deals (36115)
Drug Delivery (102)
Drug Development (77528)
Employer Resources (163)
FDA (15178)
Job Trends (14667)
News (331486)
Policy (28811)
Tag
2024 BioCapital Digital (20)
2024 BioForest Digital (16)
2024 BioForest Standard (1)
2024 BioMidwest Digital (14)
2024 BioMidwest Standard (2)
2024 Bio NC Digital (19)
2024 Bio NC Standard (1)
2024 Biotech Bay Standard (20)
2024 Biotech Beach Digital (15)
2024 Biotech Beach Standard (9)
2024 Genetown Digital (10)
2024 Genetown Standard (11)
2024 Lone Star Bio Digital (17)
2024 Pharm Country Digital (13)
2024 Pharm Country Standard (6)
2025 BioForest Digital (6)
2025 Lone Star Bio Digital (9)
2026 BioCapital Elite (1)
2026 BioCapital Standard (1)
2026 BioMidwest Elite (2)
2026 Bio NC Standard (1)
2026 Biotech Bay Elite (1)
2026 Biotech Bay Standard (1)
2026 Biotech Beach Elite (2)
2026 Genetown Elite (3)
2026 Genetown Standard (1)
2026 Pharm Country Elite (1)
2026 Pharm Country Premier (1)
2026 Pharm Country Standard (2)
Academia (1320)
Academic (1)
Accelerated approval (5)
Adcomms (13)
Allergies (83)
Alliances (46749)
ALS (94)
Alzheimer's disease (1299)
Antibody-drug conjugate (ADC) (137)
Approvals (15162)
Artificial intelligence (238)
Autoimmune disease (28)
Automation (13)
Bankruptcy (375)
Best Places to Work (10893)
BIOSECURE Act (22)
Biosimilars (97)
Biotechnology (437)
Bladder cancer (75)
Brain cancer (23)
Breast cancer (238)
Cancer (2032)
Cardiovascular disease (166)
Career advice (1760)
Career pathing (32)
CAR-T (143)
Cell therapy (413)
Cervical cancer (17)
Clinical research (63515)
Collaboration (822)
Compensation (521)
Complete response letters (27)
COVID-19 (2196)
CRISPR (39)
C-suite (250)
Cystic fibrosis (98)
Data (2027)
Decentralized trials (2)
Denatured (3)
Depression (48)
Diabetes (244)
Diagnostics (6303)
Digital health (17)
Diversity (3)
Diversity, equity & inclusion (37)
Drug discovery (113)
Drug pricing (100)
Drug shortages (24)
Duchenne muscular dystrophy (90)
Earnings (82767)
Editorial (38)
Employer branding (24)
Employer resources (139)
Events (109233)
Executive appointments (728)
FDA (16313)
Featured Employer (64)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (4)
Frontotemporal dementia (6)
Funding (730)
Gene editing (105)
Generative AI (24)
Gene therapy (291)
GLP-1 (712)
Government (2965)
Grass and pollen (6)
Guidances (46)
Healthcare (16112)
Huntington's disease (23)
IgA nephropathy (27)
Immunology and inflammation (125)
Indications (28)
Infectious disease (2332)
Inflammatory bowel disease (132)
Inflation Reduction Act (8)
Influenza (49)
Intellectual property (94)
Interviews (426)
IPO (17184)
IRA (41)
Job creations (4210)
Job search strategy (1462)
Kidney cancer (10)
Labor market (36)
Layoffs (534)
Leadership (18)
Legal (7165)
Liver cancer (68)
Lung cancer (288)
Lymphoma (133)
Machine learning (3)
Management (58)
Manufacturing (317)
MASH (65)
Medical device (13492)
Medtech (13497)
Mergers & acquisitions (19463)
Metabolic disorders (656)
Multiple sclerosis (79)
NASH (18)
Neurodegenerative disease (93)
Neuropsychiatric disorders (31)
Neuroscience (1834)
NextGen: Class of 2025 (6007)
Non-profit (2068)
Northern California (2609)
Now hiring (40)
Obesity (357)
Opinion (247)
Ovarian cancer (67)
Pain (87)
Pancreatic cancer (78)
Parkinson's disease (144)
Partnered (19)
Patents (232)
Patient recruitment (103)
Peanut (48)
People (56713)
Pharmaceutical (132)
Pharmacy benefit managers (16)
Phase I (20013)
Phase II (28399)
Phase III (21004)
Pipeline (1150)
Policy (133)
Postmarket research (1912)
Preclinical (8034)
Press Release (64)
Prostate cancer (96)
Psychedelics (35)
Radiopharmaceuticals (260)
Rare diseases (373)
Real estate (5725)
Recruiting (64)
Regulatory (20584)
Reports (35)
Research institute (1324)
Resumes & cover letters (335)
Rett syndrome (3)
RNA editing (4)
RSV (43)
Schizophrenia (75)
Series A (135)
Series B (89)
Service/supplier (26)
Sickle cell disease (51)
Southern California (2190)
Special edition (16)
Spinal muscular atrophy (147)
Sponsored (21)
Startups (3871)
State (2)
Stomach cancer (12)
Supply chain (69)
Tariffs (35)
The Weekly (50)
United States (22439)
Vaccines (654)
Venture capitalists (44)
Weight loss (240)
Women's health (24)
Worklife (18)
Date
Today (84)
Last 7 days (703)
Last 30 days (2298)
Last 365 days (32951)
2025 (9946)
2024 (35523)
2023 (40265)
2022 (50448)
2021 (53657)
2020 (50725)
2019 (42165)
2018 (32209)
2017 (32384)
2016 (30646)
2015 (36058)
2014 (28701)
2013 (23601)
2012 (25172)
2011 (25363)
2010 (23245)
Location
Africa (674)
Alabama (58)
Alaska (6)
Arizona (159)
Arkansas (11)
Asia (39868)
Australia (6511)
California (5999)
Canada (1957)
China (518)
Colorado (261)
Connecticut (275)
Delaware (135)
Europe (86926)
Florida (833)
Georgia (200)
Hawaii (1)
Idaho (55)
Illinois (448)
India (28)
Indiana (317)
Iowa (12)
Japan (151)
Kansas (98)
Kentucky (23)
Louisiana (11)
Maine (65)
Maryland (742)
Massachusetts (4625)
Michigan (229)
Minnesota (386)
Mississippi (2)
Missouri (80)
Montana (30)
Nebraska (22)
Nevada (58)
New Hampshire (65)
New Jersey (1695)
New Mexico (30)
New York (1671)
North Carolina (1040)
North Dakota (6)
Northern California (2609)
Ohio (183)
Oklahoma (11)
Oregon (40)
Pennsylvania (1308)
Puerto Rico (11)
Rhode Island (34)
South America (1064)
South Carolina (21)
South Dakota (1)
Southern California (2190)
Tennessee (82)
Texas (870)
Utah (174)
Virginia (141)
Washington D.C. (58)
Washington State (564)
West Virginia (3)
Wisconsin (48)
646,915 Results for "ert parent company".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Sialidosis Market Expected to Exhibit a CAGR of 7.4% during 2025-2035, Impelled by Research and Development in Enzyme Replacement Therapies (ERT)
February 19, 2025
·
8 min read
Press Releases
The 7 major Morquio syndrome markets are expected to exhibit a CAGR of 4.38% during 2025-2035, Impelled by Advancements in Enzyme Replacement Therapies (ERT)
February 5, 2025
·
8 min read
Press Releases
Hunter Syndrome Market Expected to Grow at a CAGR of 4.69% During 2025-2035, Impelled by Advancements in Enzyme Replacement Therapy (ERT) & Gene Therapy
January 31, 2025
·
10 min read
Press Releases
GeneDx Introduces New Telehealth Pathway to Expand Access to Exome Testing for Parents Seeking Answers
January 9, 2025
·
3 min read
BioCapital
Duchenne UK and Parent Project Muscular Dystrophy Award $500,000 to Evaluate Safety and Tolerability of Muscle Progenitor Cells in Phase 1 Trial
Parent Project Muscular Dystrophy (PPMD), a US nonprofit organization, and the UK charity Duchenne UK, two leading organizations dedicated to ending Duchenne muscular dystrophy (Duchenne), are excited to announce the recipient of their Joint Call for Therapeutic Projects.
April 23, 2024
·
5 min read
Editorial
In Wake of Elevidys Death, Duchenne Patient Community Vows to Push On
After Sarepta reported the death of a patient who had recently taken the gene therapy Elevidys, patient advocacy group Parent Project Muscular Dystrophy stepped up—as they always do.
March 20, 2025
·
3 min read
·
Annalee Armstrong
Press Releases
Kraig Biocraft Laboratories Nears Completion of Largest Production Batch of Parental Line Spider Silk Silkworms
October 14, 2024
·
3 min read
Press Releases
Aditxt Completes Third Parent Equity Investment Under Amended and Restated Merger Agreement With Evofem
October 8, 2024
·
7 min read
Press Releases
Kraig Biocraft Laboratories Leverages New Production Center for Largest Ever Batch of Spider Silk Parental Lines
October 1, 2024
·
3 min read
Policy
Ikerian (parent company of RetinAI U.S. Inc.) receives EU-MDR Certificate for four devices, its Ophthalmology Data Platform and AI models
Ikerian AG (“Ikerian”) a leader in developing software solutions for medical image and data management and artificial intelligence (AI) in healthcare, today announced the registration as Class IIa medical devices under the European Union Medical Device Regulation (Regulation (EU) 2017/745) (EU-MDR) of 4 devices.
June 24, 2024
·
3 min read
1 of 64,692
Next
